PHARMA JOURNAL | 12.01.2023 – 14:03
Responsible for the Andalusian School of Public Health of the Junta de Andalucía (EASP), the University of Granada and Roche Farma Spain have presented this Thursday the new Chair of Medicine based on the 5Ps (Personalized, Predictive, Preventive, Participatory and Population).
The presentation ceremony, held at the EASP headquarters, was attended by the General Secretary for Public Health and R+D+i of the Ministry of Health and Consumption of Andalusia, Isaac Túnez; the rector of the University of Granada, Pilar Aranda; the managing director of the Andalusian School of Public Health, Blanca Fernández-Capel; the person in charge of Personalized Medicine at Roche Farma, Teresa Ramos; and the directors of the Chair, María José Sánchez and María José Serrano, among others.
The directors of the Chair, which is a joint initiative of the three entities, have highlighted that disciplines such as genomics, digital health, and biomedical data management “are essential to successfully face the challenge of health systems in the transformation that requires personalized, precision, preventive, participatory and population medicine”. “From the Chair that we direct, we want to promote training and research in these matters to help the health system achieve excellent health care,” they indicated.
Enrique de Álava, coordinator of the Personalized and Precision Medicine Plan of the Andalusian Public Health System, was in charge of delivering the welcome conference, which dealt with “Value-based medicine: 5P health care”.
For her part, the person in charge of Personalized Medicine at Roche Farma Spain, Teresa Ramos, gave a presentation on the “Importance of public/private collaboration in Personalized Medicine” in which, among other things, she highlighted Roche’s firm commitment to when promoting the implementation of personalized medicine together with universities and public entities linked to the health system, such as the EASP. “Personalized medicine is a new way of addressing health problems that combines precision diagnosis, exhaustive analysis of health data and the development of targeted therapies, and that can only be understood through the joint effort of all of us who work in the field of health sciences”, he added.
In this sense, he highlighted that “initiatives such as this Chair, to which are added others also signed by Roche such as the Alliances in the field of precision oncology and neurosciences, place Andalusia in a privileged place to be in the leading group of the development of personalized medicine in Spain”.
The objective of the Chair is to develop scientific activities and specific projects that promote training, research, dissemination and transfer of knowledge in the field of 5P Medicine.
Follow us on social networks